pI: 5.5997 |
Length (AA): 1014 |
MW (Da): 111886 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
165 | 492 | 4pof (A) | 1 | 254 | 28.00 | 0 | 0.99 | 0.276871 | 1.14 |
243 | 903 | 4fdg (B) | 44 | 596 | 35.00 | 0 | 1 | 0.733274 | 1.47 |
331 | 906 | 4r7y (A) | 114 | 1962 | 43.00 | 0 | 1 | 0.807347 | 0.71 |
557 | 909 | 4r7z (A) | 263 | 965 | 41.00 | 0.00097 | 1 | 0.758826 | -0.21 |
911 | 1006 | 2m45 (A) | 604 | 684 | 23.00 | 0.064 | 0.88 | 0.263375 | -0.41 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 merozoite, ME49 Bradyzoite. | Hehl AB Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 Oocyst. | Fritz HM |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_127631)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G16440 | minichromosome maintenance protein 4 |
Babesia bovis | BBOV_II005160 | DNA replication licensing factor MCM4 |
Brugia malayi | Bm1_48490 | Yeast mcm |
Candida albicans | CaO19.3761 | DNA synthesis initiation |
Candida albicans | CaO19.11245 | DNA synthesis initiation |
Caenorhabditis elegans | CELE_Y39G10AR.14 | Protein MCM-4 |
Cryptosporidium hominis | Chro.20137 | DNA replication licensing factor |
Cryptosporidium parvum | cgd2_1250 | DNA replication licensing factor MCM4 like AAA+ ATpase |
Dictyostelium discoideum | DDB_G0275623 | MCM family protein |
Drosophila melanogaster | Dmel_CG1616 | disc proliferation abnormal |
Echinococcus granulosus | EgrG_000171000 | DNA replication licensing factor MCM4 |
Entamoeba histolytica | EHI_187720 | DNA replication licensing factor, putative |
Echinococcus multilocularis | EmuJ_000171000 | DNA replication licensing factor MCM4 |
Giardia lamblia | GL50803_9194 | MCM4 |
Homo sapiens | ENSG00000104738 | minichromosome maintenance complex component 4 |
Leishmania braziliensis | LbrM.09.0250 | minchromosome maintenance (MCM) complex subunit, putative |
Leishmania donovani | LdBPK_090400.1 | DNA replication licensing factor MCM4 |
Leishmania infantum | LinJ.09.0400 | minchromosome maintenance (MCM) complex subunit, putative |
Leishmania major | LmjF.09.0250 | minchromosome maintenance (MCM) complex subunit, putative |
Leishmania mexicana | LmxM.09.0250 | minchromosome maintenance (MCM) complex subunit, putative |
Loa Loa (eye worm) | LOAG_10273 | DNA replication licensing factor mcm4-B |
Mus musculus | ENSMUSG00000022673 | minichromosome maintenance deficient 4 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_060910 | DNA replication licensing factor, putative |
Plasmodium berghei | PBANKA_1415600 | DNA replication licensing factor MCM4, putative |
Plasmodium falciparum | PF3D7_1317100 | DNA replication licensing factor MCM4 |
Plasmodium knowlesi | PKNH_1417800 | DNA replication licensing factor MCM4, putative |
Plasmodium vivax | PVX_122675 | DNA replication licensing factor MCM4, putative |
Plasmodium yoelii | PY03411 | DNA replication licensing factor MCM4-related |
Saccharomyces cerevisiae | YPR019W | MCM DNA helicase complex subunit MCM4 |
Schistosoma japonicum | Sjp_0106670 | DNA replication licensing factor mcm4-B, putative |
Schistosoma japonicum | Sjp_0109260 | DNA replication licensing factor mcm4-A, putative |
Schistosoma japonicum | Sjp_0035150 | ko:K02212 minichromosome maintenance protein 4 (cell division control protein, putative |
Schistosoma mansoni | Smp_172530 | DNA replication licensing factor MCM4 |
Schmidtea mediterranea | mk4.011053.00 | DNA replication licensing factor MCM4 |
Schmidtea mediterranea | mk4.003562.01 | DNA replication licensing factor MCM4 |
Trypanosoma brucei gambiense | Tbg972.11.13690 | minichromosome maintenance (MCM) complex subunit, putative |
Trypanosoma brucei | Tb927.11.12250 | DNA replication licensing factor MCM4 |
Trypanosoma congolense | TcIL3000.11.12880 | DNA replication licensing factor MCM4, putative |
Trypanosoma cruzi | TcCLB.509023.130 | DNA replication licensing factor MCM4, putative |
Trypanosoma cruzi | TcCLB.511127.140 | DNA replication licensing factor MCM4, putative |
Toxoplasma gondii | TGME49_219700 | DNA replication licensing factor MCM4, putative |
Theileria parva | TP04_0057 | DNA replication licensing factor MCM4, putative |
Trichomonas vaginalis | TVAG_250220 | DNA replication licensing factor MCM4, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.4070 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.4070 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.4070 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.4070 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y39G10AR.14 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y39G10AR.14 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y39G10AR.14 | Caenorhabditis elegans | sterile | wormbase |
YPR019W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1415600 | Plasmodium berghei | Essential | plasmo |
TGME49_219700 this record | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.